tiprankstipranks
Trending News
More News >
Biogen (BIIB)
NASDAQ:BIIB
US Market

Biogen (BIIB) Technical Analysis

Compare
4,770 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Biogen’s (BIIB) Moving Averages Convergence Divergence (MACD) indicator is -6.97, suggesting Biogen is a Buy.
Biogen’s (BIIB) 20-Day exponential moving average is 128.88, while Biogen’s (BIIB) share price is $115.17, making it a Sell.
Biogen’s (BIIB) 50-Day exponential moving average is 137.02, while Biogen’s (BIIB) share price is $115.17, making it a Sell.

Biogen (BIIB) Pivot Points

Apr 15, 2025, 03:49 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
100.88
105.56
109.47
114.15
118.06
122.74
126.65
Fibonacci
105.56
108.84
110.87
114.15
117.43
119.46
122.74
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Biogen (BIIB) Moving Averages

Apr 15, 2025, 03:49 AM
Period
Simple
Exponential
MA5
116.46Sell
117.67Sell
MA10
123.62Sell
122.57Sell
MA20
132.42Sell
128.88Sell
MA50
137.88Sell
137.02Sell
MA100
144.82Sell
147.64Sell
MA200
172.73Sell
171.16Sell
Biogen’s (BIIB) 10-Day exponential moving average is 122.57, while Biogen’s (BIIB) share price is $115.17, making it a Sell.
Biogen’s (BIIB) 100-Day exponential moving average is 147.64, while Biogen’s (BIIB) share price is $115.17, making it a Sell.
Biogen’s (BIIB) stock price is $115.17 and Biogen’s (BIIB) 50-day simple moving average is 137.88, creating a Sell signal.
Biogen’s (BIIB) stock price is $115.17 and Biogen’s (BIIB) 100-day simple moving average is 144.82, creating a Sell signal.
Biogen’s (BIIB) stock price is $115.17 and Biogen’s (BIIB) 200-day simple moving average is 172.73, creating a Sell signal.

Biogen (BIIB) Technical Indicators

Apr 15, 2025, 03:49 AM
Name
Value
Implied Action
RSI (14)
29.57
Buy
STOCH (9,6)
21.43
Neutral
STOCHRSI (14)
18.51
Buy
MACD (12,26)
-6.97
Buy
ADX (14)
29.80
Neutral
Williams %R
-84.91
Buy
CCI (14)
-131.61
Buy
ATR (14)
5.52
-
Ultimate Oscillator
38.54
Neutral
ROC
-18.67
Sell
Biogen’s (BIIB) Relative Strength Index (RSI) is 29.57, creating a Buy signal.
Biogen’s (BIIB) Trend Strength Indicator (ADX) is 29.80, creating a Neutral signal.
Biogen’s (BIIB) Commodity Channel Index (CCI) is -131.61, creating a Buy signal.
Biogen’s (BIIB) Price Rate of Change (ROC) is -18.67, creating a Sell signal.

FAQ

Is BIIB a Buy, Hold, or Sell?
Based on BIIB’s technical indicators, BIIB is a Sell.
    What is BIIB’s RSI (14)?
    BIIB’s RSI (14) is 29.57, which suggests BIIB is a Buy.
      What is BIIB’s MACD?
      BIIB’s MACD is -6.97, which suggests BIIB is a Buy.
        What is BIIB’s 5-day moving average?
        BIIB’s 5-day moving average is 116.46, which suggests BIIB is a Sell.
          What is BIIB’s 20-day moving average?
          BIIB 20-day moving average is 132.42, which suggests BIIB is a Sell.
            What is BIIB’s 50-day moving average?
            BIIB’s 50-day moving average is 137.88, which suggests BIIB is a Sell.
              What is BIIB’s 200-day moving average?
              BIIB’s 200-day moving average is 172.73, which suggests BIIB is a Sell.
                What is BIIB’s Williams % R (14)?
                BIIB’s Williams % R (14) is -84.91, which suggests BIIB is a Buy.
                  What is BIIB’s CCI (14)?
                  BIIB’s CCI (14) is -131.61, which suggests BIIB is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis